DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Holmes jr. DR, Cannon LA, Stråhle E et al.
Four-year follow-up of the SYNTAX trial: optimal revascularization strategy in patients with three-vessel disease and/or left main disease.
San Francisco: TCT; 2011
We do not assume any responsibility for the contents of the web pages of other providers.